These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26930671)

  • 1. One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator.
    Visentin R; Man CD; Cobelli C
    IEEE Trans Biomed Eng; 2016 Nov; 63(11):2416-2424. PubMed ID: 26930671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas.
    Visentin R; Dalla Man C; Kudva YC; Basu A; Cobelli C
    Diabetes Technol Ther; 2015 Jan; 17(1):1-7. PubMed ID: 25531427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day.
    Visentin R; Campos-Náñez E; Schiavon M; Lv D; Vettoretti M; Breton M; Kovatchev BP; Dalla Man C; Cobelli C
    J Diabetes Sci Technol; 2018 Mar; 12(2):273-281. PubMed ID: 29451021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.
    Visentin R; Dalla Man C; Kovatchev B; Cobelli C
    Diabetes Technol Ther; 2014 Jul; 16(7):428-34. PubMed ID: 24571584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Closed-Loop Control Validation Studies for Optimal Insulin Delivery in Type 1 Diabetes.
    Zavitsanou S; Mantalaris A; Georgiadis MC; Pistikopoulos EN
    IEEE Trans Biomed Eng; 2015 Oct; 62(10):2369-78. PubMed ID: 25935026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.
    Toffanin C; Visentin R; Messori M; Palma FD; Magni L; Cobelli C
    IEEE Trans Biomed Eng; 2018 Mar; 65(3):479-488. PubMed ID: 28092515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator.
    Visentin R; Klabunde T; Grant M; Dalla Man C; Cobelli C
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():3250-3. PubMed ID: 26736985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Day-to-Day Variability of Glucose-Insulin Regulation Over 12-Week Home Use of Closed-Loop Insulin Delivery.
    Yue Ruan ; Wilinska ME; Thabit H; Hovorka R
    IEEE Trans Biomed Eng; 2017 Jun; 64(6):1412-1419. PubMed ID: 28113240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control-Oriented Model With Intra-Patient Variations for an Artificial Pancreas.
    Moscoso-Vasquez M; Colmegna P; Rosales N; Garelli F; Sanchez-Pena R
    IEEE J Biomed Health Inform; 2020 Sep; 24(9):2681-2689. PubMed ID: 31995506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Padova Type 2 Diabetes Simulator from Triple-Tracer Single-Meal Studies:
    Visentin R; Cobelli C; Dalla Man C
    Diabetes Technol Ther; 2020 Dec; 22(12):892-903. PubMed ID: 32324063
    [No Abstract]   [Full Text] [Related]  

  • 11. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.
    Kovatchev BP; Breton M; Man CD; Cobelli C
    J Diabetes Sci Technol; 2009 Jan; 3(1):44-55. PubMed ID: 19444330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replay Simulations with Personalized Metabolic Model for Treatment Design and Evaluation in Type 1 Diabetes.
    Hughes J; Gautier T; Colmegna P; Fabris C; Breton MD
    J Diabetes Sci Technol; 2021 Nov; 15(6):1326-1336. PubMed ID: 33218280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing risks in type 1 diabetes using H∞ control.
    Colmegna P; Sanchez Pena RS; Gondhalekar R; Dassau E; Doyle Iii FJ
    IEEE Trans Biomed Eng; 2014 Dec; 61(12):2939-47. PubMed ID: 25020013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility.
    Cobelli C; Kovatchev B
    J Diabetes Sci Technol; 2023 Nov; 17(6):1493-1505. PubMed ID: 37743740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing Glucose Variability Due to Meals and Postprandial Exercise in T1DM Using Switched LPV Control: In Silico Studies.
    Colmegna PH; Sánchez-Peña RS; Gondhalekar R; Dassau E; Doyle FJ
    J Diabetes Sci Technol; 2016 May; 10(3):744-53. PubMed ID: 27022097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties.
    Shi D; Dassau E; Doyle FJ
    IEEE Trans Biomed Eng; 2019 Apr; 66(4):1045-1054. PubMed ID: 30142748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insulin infusion advisory system based on autotuning nonlinear model-predictive control.
    Zarkogianni K; Vazeou A; Mougiakakou SG; Prountzou A; Nikita KS
    IEEE Trans Biomed Eng; 2011 Sep; 58(9):2467-77. PubMed ID: 21622071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic bolus and adaptive basal algorithm for the artificial pancreatic β-cell.
    Wang Y; Dassau E; Zisser H; Jovanovič L; Doyle FJ
    Diabetes Technol Ther; 2010 Nov; 12(11):879-87. PubMed ID: 20879966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator
    Visentin R; Schiavon M; Giegerich C; Klabunde T; Man CD; Cobelli C
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():4905-4908. PubMed ID: 30441443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial pancreas: model predictive control design from clinical experience.
    Toffanin C; Messori M; Di Palma F; De Nicolao G; Cobelli C; Magni L
    J Diabetes Sci Technol; 2013 Nov; 7(6):1470-83. PubMed ID: 24351173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.